Collaborative membrane activity and receptor-dependent tumor cell targeting for precise nanoparticle delivery in

Rita Sala1, Laura Sánchez-García2, Naroa Serna2

  • 1CIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), C/Monforte de Lemos 3-5, 28029 Madrid, Spain; Institut d'Investigacions Biomèdiques Sant Pau and Josep Carreras Research Institute, Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain.

Acta Biomaterialia
|September 9, 2019
PubMed

Insights

Researchers created multifunctional protein nanoparticles that precisely target and accumulate in CXCR4-positive colorectal tumors. This approach enhances drug delivery and cancer therapy by combining cell targeting with improved endosomal escape.

Area of Science:

  • Biotechnology
  • Nanomedicine
  • Molecular Biology

Background:

  • Targeted drug delivery systems are crucial for effective cancer therapy.
  • Multifunctional protein nanoparticles offer potential for precise tumor targeting and enhanced therapeutic efficacy.

Purpose of the Study:

  • To engineer multifunctional protein nanoparticles combining CXCR4-positive cell binding and endosomal escape capabilities.
  • To evaluate the in vivo tumor accumulation and biodistribution of these nanoparticles in colorectal cancer models.

Main Methods:

  • Constructing protein nanoparticles with specific functional peptides (T22, HA2) and a reporter (GFP).
  • Administering nanoparticles to mouse models of human CXCR4-positive colorectal cancer.
  • Utilizing CXCR4 antagonists to confirm tumor selectivity.

Main Results:

  • Engineered nanoparticles demonstrated significantly higher accumulation in primary tumors compared to control versions.
  • CXCR4-positive tumor tissue selectivity was confirmed in vivo.
  • Enhanced endosomal escape contributed to precise and efficient tumor biodistribution.

Conclusions:

  • Functional peptide recruitment is a viable strategy for creating protein materials for clinical applications.
  • Enhancing non-specific membrane activity can improve, not compromise, selective cell targeting.
  • These findings advance the rational design of protein nanomaterials for improved cancer therapies.

Related Concept Videos

Isolation of Circulating Tumor Cells in an Orthotopic Mouse Model of Colorectal Cancer06:19

Isolation of Circulating Tumor Cells in an Orthotopic Mouse Model of Colorectal Cancer

We describe the establishment of orthotopic colorectal tumors via injection of tumor cells or organoids into the cecum of mice and the subsequent isolation of circulating tumor cells (CTCs) from this model.
10.7K
Intracecal Tumor Cell Injection: A Technique to Deliver Cancer Cells for Establishing Orthotopic Colorectal Cancer Mouse Model04:08

Intracecal Tumor Cell Injection: A Technique to Deliver Cancer Cells for Establishing Orthotopic Colorectal Cancer Mouse Model

The video describes the technique for intracecal injection of cancerous cells to develop an orthotopic mouse model with highly uniform tumors. Therefore, the orthotopic mouse model allows realistic simulation of metastasis, providing a valuable tool to study the phenotype changes during tumor growth and...
5.0K
Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier10:16

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier

A liquid crystal nanoparticle (LCNP) nanocarrier is exploited as a vehicle for the controlled delivery of a hydrophobic cargo to the plasma membrane of living...
8.0K
Functionalized Nanoparticle Targeting of Ovarian Cancer: A Technique to Facilitate Folic Acid-conjugated Nanoparticle Contrast Agent Uptake by Ovarian Cancer Cells02:53

Functionalized Nanoparticle Targeting of Ovarian Cancer: A Technique to Facilitate Folic Acid-conjugated Nanoparticle Contrast Agent Uptake by Ovarian Cancer Cells

In this video, we demonstrate a technique to facilitate the internalization of folic acid-capped copper sulfide nanoparticles (CuS NPs). Folic acid-functionalized CuS NPs have the ability to target folate-receptors which are overexpressed in many ovarian cancer...
3.3K
Establishment of a Co-culture System of Patient-Derived Colorectal Tumor Organoids and Tumor-Infiltrating Lymphocytes (TILs)08:42

Establishment of a Co-culture System of Patient-Derived Colorectal Tumor Organoids and Tumor-Infiltrating Lymphocytes (TILs)

The protocol describes a method for creating a patient-derived colorectal cancer (CRC) organoid model co-cultured with tumor-infiltrating lymphocytes (TILs) to study their interactions and therapeutic potential. This model provides a preclinical platform to explore immune responses in the tumor microenvironment and to predict the efficacy of TIL-based therapy for personalized CRC...
2.1K
Molecular Profiling of the Invasive Tumor Microenvironment in a 3-Dimensional Model of Colorectal Cancer Cells and Ex vivo Fibroblasts10:33

Molecular Profiling of the Invasive Tumor Microenvironment in a 3-Dimensional Model of Colorectal Cancer Cells and Ex vivo Fibroblasts

Molecular profiling of laser microdissected cells and stroma from synthetic, tissue-engineered colorectal cancer models represents a novel and manipulatable approach to characterize and dissect the distinctive biology at the interface between tumor cells at the invasive front and cancer associated stromal cells.
11.5K